Midgard Finance drug data

Search the drug boards by free text and by field.

Full record for one drug, with its efficacy figures estimand-tagged and its page URL. Matching goes slug, then exact name or brand, then substring, so "wegovy", "Wegovy HD" and "semaglutide-obesity" all land somewhere sensible without the caller knowing the slug scheme.

One trial's design, by NCT number or by trial key (SURMOUNT-1, scale, redefine-1).

The extracted weight-loss table for the named drugs, joined to trial design, one row per arm and timepoint. Rows are NOT collapsed to one number per drug. The corpus holds several doses, timepoints and estimands per trial, and picking a single winner per drug would mean choosing between them here, silently and on the caller's behalf. The comparison is theirs to make; this returns the rows and the labels needed to make it correctly.

Extracted adverse-event rates for a named drug or trial, by arm, with the arithmetic that was checked. `verification` is carried through verbatim. It is the raw-count recomputation recorded when the row was extracted ("997/2481 active = 40.18%"), and it is what lets a caller see that the percentage was checked against the paper rather than copied from an abstract.

The digitised weight-loss curve for a drug: week-by-week points, plus per-dose series. Returned with `endpoint_pct` and its estimand alongside the curve, because the endpoint marker and the last plotted point are different quantities and the curve alone does not say which one a reader is looking at.

Upcoming and recent readouts, approvals and trial starts across sponsors. Dates are ISO strings where the event has a date and a bare year where the sponsor has only guided to one, so they are compared as strings rather than parsed - "2026" sorts before "2026-07-01", which is the right answer for an event guided to a year.